NPI: 1598715401 · TOMAHAWK, WI 54487 · General Acute Care Hospital · NPI assigned 05/11/2006
Authorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
| Authorized Official | YANG, JERRY (SVP & CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 05/11/2006 |
Other providers sharing the same authorized official: YANG, JERRY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,522 | $559K |
| 2019 | 10,643 | $558K |
| 2020 | 7,284 | $415K |
| 2021 | 7,879 | $463K |
| 2022 | 7,662 | $533K |
| 2023 | 8,316 | $669K |
| 2024 | 6,067 | $406K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,525 | 3,698 | $1.01M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,670 | 2,173 | $669K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,016 | 1,625 | $494K |
| 96361 | Intravenous infusion, hydration; each additional hour | 893 | 632 | $479K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,680 | 1,324 | $354K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,189 | 2,682 | $102K |
| 70450 | Computed tomography, head or brain; without contrast material | 165 | 142 | $56K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 183 | 175 | $39K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,596 | 1,428 | $37K |
| 80053 | Comprehensive metabolic panel | 4,656 | 3,695 | $34K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,870 | 1,259 | $32K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 279 | 255 | $32K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 344 | 299 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,742 | 4,391 | $27K |
| 71046 | Radiologic examination, chest; 2 views | 958 | 785 | $23K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 61 | 53 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,468 | 1,297 | $19K |
| 80061 | Lipid panel | 1,618 | 1,464 | $17K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 72 | 52 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,613 | 2,166 | $17K |
| 99001 | 1,855 | 1,538 | $11K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 830 | 312 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 288 | 255 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,168 | 1,033 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 91 | 81 | $7K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 47 | 37 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 14 | 13 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 339 | 306 | $5K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 407 | 340 | $5K |
| 81001 | 1,952 | 1,595 | $4K | |
| 84484 | 758 | 560 | $4K | |
| 83735 | 669 | 549 | $2K | |
| 85610 | 692 | 471 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 6,281 | 4,820 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 30 | 27 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,666 | 1,331 | $1K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 159 | 69 | $759.89 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 141 | 125 | $668.92 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 17 | 14 | $575.55 |
| 90686 | 57 | 54 | $463.74 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 987 | 783 | $410.59 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 14 | $402.77 |
| 81003 | 251 | 212 | $396.28 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 303 | 213 | $350.20 |
| 85027 | 70 | 55 | $277.56 | |
| 83690 | 67 | 54 | $267.94 | |
| 83605 | 54 | 42 | $203.10 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 14 | 14 | $164.24 |
| 71045 | Radiologic examination, chest; single view | 130 | 111 | $163.85 |
| 84439 | 16 | 13 | $133.86 | |
| 81025 | 21 | 13 | $85.70 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 718 | 540 | $50.92 |
| 85730 | 12 | 12 | $37.75 | |
| 87088 | 12 | 12 | $33.44 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 676 | 498 | $26.49 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 195 | 153 | $5.00 |
| 90674 | 34 | 29 | $0.49 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 341 | 271 | $0.11 |
| A9270 | Non-covered item or service | 202 | 130 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 55 | 46 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 142 | 116 | $0.00 |